397 related articles for article (PubMed ID: 23226683)
21. Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.
Tewari K; Flynn BJ; Boscardin SB; Kastenmueller K; Salazar AM; Anderson CA; Soundarapandian V; Ahumada A; Keler T; Hoffman SL; Nussenzweig MC; Steinman RM; Seder RA
Vaccine; 2010 Oct; 28(45):7256-66. PubMed ID: 20846528
[TBL] [Abstract][Full Text] [Related]
22. Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate.
Milich DR; Hughes J; Jones J; Sällberg M; Phillips TR
Vaccine; 2001 Dec; 20(5-6):771-88. PubMed ID: 11738741
[TBL] [Abstract][Full Text] [Related]
23. Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences.
Hayashi CTH; Cao Y; Zavala F; Simonyan H; Young CN; Kumar N
Vaccine; 2023 Nov; 41(46):6824-6833. PubMed ID: 37827967
[TBL] [Abstract][Full Text] [Related]
24. Extended protection capabilities of an immature dendritic-cell targeting malaria sporozoite vaccine.
Luo K; Zavala F; Gordy J; Zhang H; Markham RB
Vaccine; 2017 Apr; 35(18):2358-2364. PubMed ID: 28342669
[TBL] [Abstract][Full Text] [Related]
25. Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model.
Amelia F; Iyori M; Emran TB; Yamamoto DS; Genshi K; Otsuka H; Onoue Y; Yusuf Y; Islam A; Yoshida S
Parasite Immunol; 2019 May; 41(5):e12624. PubMed ID: 30883819
[TBL] [Abstract][Full Text] [Related]
26. A replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys.
Karen KA; Deal C; Adams RJ; Nielsen C; Ward C; Espinosa DA; Xie J; Zavala F; Ketner G
Infect Immun; 2015 Jan; 83(1):268-75. PubMed ID: 25368113
[TBL] [Abstract][Full Text] [Related]
27. Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque.
Virnik K; Zhou W; Medvedev A; Walsh G; Perry-Anderson J; Majam V; Felber BK; Kumar S; Berkower I
Biochem Biophys Res Commun; 2021 Nov; 577():58-63. PubMed ID: 34507066
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
[TBL] [Abstract][Full Text] [Related]
29. A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates.
Kubler-Kielb J; Majadly F; Biesova Z; Mocca CP; Guo C; Nussenzweig R; Nussenzweig V; Mishra S; Wu Y; Miller LH; Keith JM; Liu TY; Robbins JB; Schneerson R
Proc Natl Acad Sci U S A; 2010 Jan; 107(3):1172-7. PubMed ID: 20080619
[TBL] [Abstract][Full Text] [Related]
30. An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens.
Rodríguez-Galán A; Salman AM; Bowyer G; Collins KA; Longley RJ; Brod F; Ulaszewska M; Ewer KJ; Janse CJ; Khan SM; Hafalla JC; Hill AVS; Spencer AJ
Sci Rep; 2017 Dec; 7(1):17011. PubMed ID: 29209029
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations.
Tamborrini M; Stoffel SA; Westerfeld N; Amacker M; Theisen M; Zurbriggen R; Pluschke G
Malar J; 2011 Dec; 10():359. PubMed ID: 22166048
[TBL] [Abstract][Full Text] [Related]
32. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.
Wang LT; Pereira LS; Kiyuka PK; Schön A; Kisalu NK; Vistein R; Dillon M; Bonilla BG; Molina-Cruz A; Barillas-Mury C; Tan J; Idris AH; Francica JR; Seder RA
PLoS Pathog; 2021 Dec; 17(12):e1010133. PubMed ID: 34871332
[TBL] [Abstract][Full Text] [Related]
33. Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein.
Gregson AL; Oliveira G; Othoro C; Calvo-Calle JM; Thorton GB; Nardin E; Edelman R
PLoS One; 2008 Feb; 3(2):e1556. PubMed ID: 18253503
[TBL] [Abstract][Full Text] [Related]
34. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.
Sina BJ; do Rosario VE; Woollett G; Sakhuja K; Hollingdale MR
Exp Parasitol; 1993 Sep; 77(2):129-35. PubMed ID: 8375482
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.
Teixeira LH; Tararam CA; Lasaro MO; Camacho AG; Ersching J; Leal MT; Herrera S; Bruna-Romero O; Soares IS; Nussenzweig RS; Ertl HC; Nussenzweig V; Rodrigues MM
Infect Immun; 2014 Feb; 82(2):793-807. PubMed ID: 24478093
[TBL] [Abstract][Full Text] [Related]
36. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.
Chatterjee S; Wery M; Sharma P; Chauhan VS
Infect Immun; 1995 Nov; 63(11):4375-81. PubMed ID: 7591073
[TBL] [Abstract][Full Text] [Related]
37. A chemokine-fusion vaccine targeting immature dendritic cells elicits elevated antibody responses to malaria sporozoites in infant macaques.
Luo K; Gordy JT; Zavala F; Markham RB
Sci Rep; 2021 Jan; 11(1):1220. PubMed ID: 33441615
[TBL] [Abstract][Full Text] [Related]
38. Re-investigation of the circumsporozoite protein-based induction of sterile immunity against Plasmodium berghei infection.
Reed RC; Louis-Wileman V; Wells RL; Verheul AF; Hunter RL; Lal AA
Vaccine; 1996 Jun; 14(8):828-36. PubMed ID: 8817831
[TBL] [Abstract][Full Text] [Related]
39. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.
Nguyen TV; Sacci JB; de la Vega P; John CC; James AA; Kang AS
Malar J; 2009 Oct; 8():235. PubMed ID: 19852802
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice.
Palma C; Overstreet MG; Guedon JM; Hoiczyk E; Ward C; Karen KA; Zavala F; Ketner G
Vaccine; 2011 Feb; 29(8):1683-9. PubMed ID: 21199707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
